ArticleFrontiers in oncology2021

Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot Study.

Michael Kharouta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.